• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

城市血液透析单元中的 COVID-19 疫情爆发。

COVID-19 Outbreak in an Urban Hemodialysis Unit.

机构信息

St. Michael's Hospital, Toronto, Canada.

Centre Hospitalier de l'Université de Montréal, Montréal, Canada.

出版信息

Am J Kidney Dis. 2020 Nov;76(5):690-695.e1. doi: 10.1053/j.ajkd.2020.07.001. Epub 2020 Jul 15.

DOI:10.1053/j.ajkd.2020.07.001
PMID:32681983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7362862/
Abstract

RATIONALE & OBJECTIVE: Hemodialysis patients are at increased risk for coronavirus disease 2019 (COVID-19) transmission due in part to difficulty maintaining physical distancing. Our hemodialysis unit experienced a COVID-19 outbreak despite following symptom-based screening guidelines. We describe the course of the COVID-19 outbreak and the infection control measures taken for mitigation.

STUDY DESIGN

Retrospective cohort study.

SETTING & PARTICIPANTS: 237 maintenance hemodialysis patients and 93 hemodialysis staff at a single hemodialysis center in Toronto, Canada.

EXPOSURE

Universal screening of patients and staff for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

OUTCOMES

The primary outcome was detection of SARS-CoV-2 in nasopharyngeal samples from patients and staff using reverse transcriptase-polymerase chain reaction (RT-PCR).

ANALYTICAL APPROACH

Descriptive statistics were used for clinical characteristics and the primary outcome.

RESULTS

11 of 237 (4.6%) hemodialysis patients and 11 of 93 (12%) staff members had a positive RT-PCR test result for SARS-CoV-2. Among individuals testing positive, 12 of 22 (55%) were asymptomatic at time of testing and 7 of 22 (32%) were asymptomatic for the duration of follow-up. One patient was hospitalized at the time of SARS-CoV-2 infection and 4 additional patients with positive test results were subsequently hospitalized. 2 (18%) patients required admission to the intensive care unit. After 30 days' follow-up, no patients had died or required mechanical ventilation. No hemodialysis staff required hospitalization. Universal droplet and contact precautions were implemented during the outbreak. Hemodialysis staff with SARS-CoV-2 infection were placed on home quarantine regardless of symptom status. Patients with SARS-CoV-2 infection, including asymptomatic individuals, were treated with droplet and contact precautions until confirmation of negative SARS-CoV-2 RT-PCR test results. Analysis of the outbreak identified 2 index cases with subsequent nosocomial transmission within the dialysis unit and in shared shuttle buses to the hemodialysis unit.

LIMITATIONS

Single-center study.

CONCLUSIONS

Universal SARS-CoV-2 testing and universal droplet and contact precautions in the setting of an outbreak appeared to be effective in preventing further transmission.

摘要

背景与目的

由于难以保持身体距离,血液透析患者感染 2019 年冠状病毒病(COVID-19)的风险增加。尽管我们的血液透析单位遵循基于症状的筛查指南,但仍发生了 COVID-19 爆发。我们描述了 COVID-19 爆发的过程以及为减轻其影响而采取的感染控制措施。

研究设计

回顾性队列研究。

地点和参与者

加拿大多伦多一家血液透析中心的 237 名维持性血液透析患者和 93 名血液透析工作人员。

暴露情况

对患者和工作人员进行普遍筛查,以检测严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)。

主要结局

使用逆转录酶-聚合酶链反应(RT-PCR)从患者和工作人员的鼻咽样本中检测 SARS-CoV-2。

分析方法

使用描述性统计数据进行临床特征和主要结局分析。

结果

237 名血液透析患者中有 11 名(4.6%)和 93 名工作人员中有 11 名(12%)的 RT-PCR 检测结果为 SARS-CoV-2 阳性。在检测结果呈阳性的个体中,12 名(55%)在检测时无症状,7 名(32%)在随访期间无症状。1 名患者在感染 SARS-CoV-2 时住院,另外 4 名检测结果呈阳性的患者随后住院。2 名(18%)患者需要入住重症监护病房。经过 30 天的随访,没有患者死亡或需要机械通气。没有血液透析工作人员需要住院治疗。在爆发期间实施了普遍的飞沫和接触预防措施。无论症状如何,感染 SARS-CoV-2 的血液透析工作人员均被居家隔离。感染 SARS-CoV-2 的患者,包括无症状患者,在确认 SARS-CoV-2 RT-PCR 检测结果阴性之前,均接受飞沫和接触预防措施治疗。对疫情的分析确定了 2 名索引病例,随后在透析病房和前往透析病房的共用班车中发生了院内传播。

局限性

单中心研究。

结论

在爆发期间,普遍进行 SARS-CoV-2 检测和普遍采取飞沫和接触预防措施似乎可有效防止进一步传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6448/7362862/c9d2ad6ce201/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6448/7362862/a3df466bd694/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6448/7362862/dc07bca5252b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6448/7362862/c9d2ad6ce201/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6448/7362862/a3df466bd694/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6448/7362862/dc07bca5252b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6448/7362862/c9d2ad6ce201/gr2_lrg.jpg

相似文献

1
COVID-19 Outbreak in an Urban Hemodialysis Unit.城市血液透析单元中的 COVID-19 疫情爆发。
Am J Kidney Dis. 2020 Nov;76(5):690-695.e1. doi: 10.1053/j.ajkd.2020.07.001. Epub 2020 Jul 15.
2
Hemodialysis with Cohort Isolation to Prevent Secondary Transmission during a COVID-19 Outbreak in Korea.韩国 COVID-19 疫情期间采用队列隔离进行血液透析以预防二次传播。
J Am Soc Nephrol. 2020 Jul;31(7):1398-1408. doi: 10.1681/ASN.2020040461. Epub 2020 Jun 1.
3
Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China.血清学检测在血液透析中心的 SARS-CoV-2 感染: 在中国武汉的一项多中心回顾性研究。
Am J Kidney Dis. 2020 Oct;76(4):490-499.e1. doi: 10.1053/j.ajkd.2020.06.008. Epub 2020 Jul 3.
4
COVID-19 and ESKD, A Rapid Review.《2019冠状病毒病与终末期肾病:快速综述》
R I Med J (2013). 2020 Sep 4;103(8):29-33.
5
Containment of a Large SARS-CoV-2 Outbreak Among Healthcare Workers in a Pediatric Intensive Care Unit.在儿科重症监护病房中控制医护人员中大规模 SARS-CoV-2 爆发。
Pediatr Infect Dis J. 2020 Nov;39(11):e336-e339. doi: 10.1097/INF.0000000000002866.
6
Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong.2019 年冠状病毒病在医院环境中的传播风险:香港普通病房的经验。
J Hosp Infect. 2020 Jun;105(2):119-127. doi: 10.1016/j.jhin.2020.03.036. Epub 2020 Apr 4.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
Surveillance of SARS-CoV-2 infection among frontline health care workers in Wuhan during COVID-19 outbreak.COVID-19 疫情期间武汉一线医护人员中 SARS-CoV-2 感染的监测。
Immun Inflamm Dis. 2020 Dec;8(4):840-843. doi: 10.1002/iid3.340. Epub 2020 Aug 20.
9
[The peak of the Coronavirus emergency and hemodialysis patients: the experience of the Dialysis Center in Crema].[新型冠状病毒紧急情况高峰期与血液透析患者:克雷马透析中心的经验]
G Ital Nefrol. 2020 Oct 5;37(5):2020-vol5.
10
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.

引用本文的文献

1
Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection.瑞士透析人群中与2019冠状病毒病大流行相关的死亡率,不包括严重急性呼吸综合征冠状病毒2感染。
Clin Kidney J. 2024 Oct 29;17(12):sfae322. doi: 10.1093/ckj/sfae322. eCollection 2024 Dec.
2
Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Healthcare Personnel in El Salvador Prior to Vaccination Campaigns.萨尔瓦多疫苗接种运动开展前医护人员中抗SARS-CoV-2 IgG抗体的血清流行率
Infect Dis Rep. 2024 Jun 7;16(3):531-542. doi: 10.3390/idr16030040.
3
COVID-19 incidence and outcomes among patients with kidney replacement therapy.

本文引用的文献

1
Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China.血清学检测在血液透析中心的 SARS-CoV-2 感染: 在中国武汉的一项多中心回顾性研究。
Am J Kidney Dis. 2020 Oct;76(4):490-499.e1. doi: 10.1053/j.ajkd.2020.06.008. Epub 2020 Jul 3.
2
Epidemiology of COVID-19 in an Urban Dialysis Center.城市透析中心的 COVID-19 流行病学。
J Am Soc Nephrol. 2020 Aug;31(8):1815-1823. doi: 10.1681/ASN.2020040534. Epub 2020 Jun 19.
3
False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications.
接受肾脏替代治疗的患者中新冠病毒疾病2019的发病率及治疗结果
Kidney Res Clin Pract. 2023 Sep;42(5):649-659. doi: 10.23876/j.krcp.22.240. Epub 2023 Sep 27.
4
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease.接受 BNT162b2 BA.4/5 或 mRNA-1273 BA.1 二价疫苗接种的终末期肾病患者体内针对奥密克戎变异株的中和抗体。
Nat Commun. 2023 Sep 27;14(1):6041. doi: 10.1038/s41467-023-41678-9.
5
Impact of the COVID-19 Pandemic on the Provision of Dialysis Service and Mortality in Veterans Receiving Maintenance Hemodialysis in the VA: An Interrupted Time-Series Analysis.COVID-19 大流行对退伍军人事务部维持性血液透析患者透析服务提供和死亡率的影响:一项中断时间序列分析。
Am J Nephrol. 2023;54(11-12):508-515. doi: 10.1159/000532105. Epub 2023 Jul 31.
6
Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine.COVID-19 感染在透析患者中的临床表现和 COVID-19 疫苗的保护作用。
Inflamm Res. 2023 May;72(5):989-1000. doi: 10.1007/s00011-023-01723-1. Epub 2023 Apr 1.
7
COVID-19 in Elderly Patients Receiving Haemodialysis: A Current Review.接受血液透析的老年患者中的 COVID-19:当前综述
Biomedicines. 2023 Mar 16;11(3):926. doi: 10.3390/biomedicines11030926.
8
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research Protocol.确定慢性肾脏病患者对COVID-19疫苗接种的纵向血清学反应:一项临床研究方案。
Can J Kidney Health Dis. 2023 Mar 20;10:20543581231160511. doi: 10.1177/20543581231160511. eCollection 2023.
9
COVID - 19 in two dialysis centers situated in two neighbouring states of the Western Balkans.巴尔干西部两个相邻州的两家透析中心的 COVID-19 疫情。
BMC Nephrol. 2023 Feb 18;24(1):40. doi: 10.1186/s12882-023-03080-x.
10
Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease.研究设计对5期慢性肾脏病患者2剂mRNA新冠疫苗有效性评估的影响
Kidney Int. 2023 Apr;103(4):791-797. doi: 10.1016/j.kint.2023.01.009. Epub 2023 Jan 31.
新型冠状病毒2型感染的假阴性检测——挑战与影响
N Engl J Med. 2020 Aug 6;383(6):e38. doi: 10.1056/NEJMp2015897. Epub 2020 Jun 5.
4
Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.中国武汉血液透析患者 COVID-19 的临床特征和医学干预措施。
J Am Soc Nephrol. 2020 Jul;31(7):1387-1397. doi: 10.1681/ASN.2020030354. Epub 2020 May 8.
5
Mild or Moderate Covid-19.轻度或中度新冠病毒感染
N Engl J Med. 2020 Oct 29;383(18):1757-1766. doi: 10.1056/NEJMcp2009249. Epub 2020 Apr 24.
6
Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19.无症状传播,当前控制新冠疫情策略的致命弱点。
N Engl J Med. 2020 May 28;382(22):2158-2160. doi: 10.1056/NEJMe2009758. Epub 2020 Apr 24.
7
Maintenance Hemodialysis and COVID-19: Saving Lives With Caution, Care, and Courage.维持性血液透析与2019冠状病毒病:谨慎、关怀与勇气拯救生命
Kidney Med. 2020 Mar 26;2(3):365-366. doi: 10.1016/j.xkme.2020.03.003. eCollection 2020 May-Jun.
8
COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?新冠病毒与透析单位:我们目前了解到了什么以及我们应该怎么做?
Am J Kidney Dis. 2020 Jul;76(1):1-3. doi: 10.1053/j.ajkd.2020.03.008. Epub 2020 Mar 23.
9
Mitigating Risk of COVID-19 in Dialysis Facilities.降低透析机构中新冠病毒病的风险
Clin J Am Soc Nephrol. 2020 May 7;15(5):707-709. doi: 10.2215/CJN.03340320. Epub 2020 Mar 20.
10
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.流行病学观察性研究报告强化(STROBE)声明:观察性研究报告指南
BMJ. 2007 Oct 20;335(7624):806-8. doi: 10.1136/bmj.39335.541782.AD.